quest
mean
prevent
rabi
human
loui
pasteur
initi
research
anim
rabi
vaccin
franc
earli
bunn
viru
obtain
rabid
dog
first
serial
pass
rabbit
intracerebr
inocul
specifi
time
interv
dog
vaccin
variou
time
interv
challeng
rabi
viru
although
method
produc
accept
result
pasteur
found
serial
intracerebr
inocul
monkey
dog
origin
viru
incub
period
increas
virul
viru
decreas
use
regimen
pasteur
demonstr
dog
vaccin
resist
subsequ
challeng
virul
street
nonlaboratori
propag
rabi
viru
pasteur
attenu
weaken
viru
desicc
bunn
improv
safeti
earli
attempt
produc
rabi
vaccin
review
friedberg
frohner
report
hogy
protopopoff
other
conduct
studi
improv
safeti
efficaci
vaccin
dog
reduc
number
dose
need
first
intern
rabi
confer
recommend
fix
viru
canin
rabi
vaccin
complet
inactiv
attenu
caus
diseas
dog
vaccin
either
subcutan
sc
intramuscularli
im
schoenig
next
sever
decad
virtual
rabi
nerv
tissu
origin
nto
vaccin
inactiv
phenol
use
method
describ
sempl
bunn
nto
vaccin
current
use
mass
vaccin
campaign
africa
latin
america
caribbean
primarili
produc
rabi
virusinfect
suckl
mous
brain
lamb
brain
vaccin
shown
effect
campaign
howev
nto
kill
vaccin
dog
anim
often
past
result
postvaccin
nervou
system
reaction
could
result
death
vaccin
anim
bunn
better
vaccin
need
embryon
chicken
egg
use
koprowski
cox
serial
passag
fluri
strain
human
rabi
viru
isol
viru
initi
pass
time
chick
vaccin
produc
chicken
embryo
passag
lost
viscerotrop
properti
retain
neurotrop
properti
design
fluri
lowegg
passag
lep
effect
dog
vaccin
occasion
caus
rabi
young
pup
cat
cattl
bunn
increas
safeti
vaccin
speci
koprowski
et
al
increas
passag
fluri
strain
embryon
egg
viru
found
nonpathogen
dog
inocul
intracerebr
follow
passag
fluri
highegg
passag
hep
vaccin
declar
safe
im
use
cat
cattl
well
puppi
month
age
howev
sinc
case
vaccineinduc
rabi
occur
cat
administ
im
fluryhep
vaccin
later
withdrawn
market
cabasso
etal
dean
guevin
fluri
kelev
strain
rabi
viru
use
produc
chick
embryo
origin
ceo
modifi
live
viru
mlv
vaccin
tissu
cultur
tc
vaccin
deriv
street
alabama
dufferin
sad
strain
adapt
hamster
kidney
cell
fenji
evelynrokitnickiabelseth
era
strain
grown
porcin
kidney
cell
abelseth
commonli
use
produc
mlv
vaccin
reculard
sever
mlv
vaccin
produc
year
mlv
vaccin
especi
use
ceo
sad
era
strain
still
use
extens
asia
africa
part
europ
adapt
oral
immun
carnivor
includ
domest
dog
cat
blancou
meslin
tc
mlv
vaccin
produc
fewer
allerg
reaction
ceo
vaccin
potenc
test
mlv
vaccin
anim
use
consist
measur
titer
infecti
viru
anim
vaccin
sampl
fill
lot
see
section
titer
high
prove
efficaci
speci
anim
vaccin
intend
vaccin
releas
use
sizaret
even
though
mlv
vaccin
trustworthi
year
use
inactiv
kill
cell
cultur
vaccin
increas
area
world
mlv
vaccin
still
use
recommend
mlv
vaccin
parenter
use
anim
mlv
rabi
vaccin
current
licens
use
usa
concept
oral
rabi
vaccin
orv
first
proven
success
baer
et
al
use
sad
bern
strain
viru
adapt
era
strain
sever
type
mlv
orv
vaccin
produc
use
bait
freerang
anim
serv
vector
mainten
transmiss
diseas
wildlif
speci
orv
use
extens
europ
sinc
canada
consider
success
isara
et
al
aubert
et
al
unfortun
liveviru
sad
vaccin
contain
degre
residu
pathogen
wild
rodent
artoi
et
al
result
partial
impair
immun
respons
fox
cub
week
old
born
sad
b
vixen
result
insuffici
protect
rabi
muller
et
al
sinc
earli
sad
strain
use
vaccin
replac
sadavirulentgif
strain
develop
vaccin
strain
strain
choic
doubl
mutant
isol
sad
bern
strain
two
success
select
step
util
antiglycoprotein
monoclon
antibodi
strain
avirul
follow
intracerebr
inocul
immunocompet
mice
protect
mice
challeng
challeng
viru
standard
cv
lafay
et
al
strain
rabi
viru
packag
chickenhead
bait
success
protect
captiv
african
wild
dog
rabi
challeng
knobel
et
al
studi
conduct
center
diseas
control
prevent
atlanta
georgia
usa
vaccin
produc
clinic
ill
laboratori
vaccin
beagl
residu
viru
isol
one
oral
swab
dog
fekadu
et
al
orciari
et
al
orv
deriv
sadsag
origin
vaccin
current
licens
use
usa
compendium
recombin
vaccinia
viru
express
rabi
viru
glycoprotein
gene
vrg
develop
insert
cdna
glycoprotein
gene
era
strain
thymidin
kinas
gene
copenhagen
strain
vaccinia
viru
initi
studi
new
orv
conduct
determin
whether
vrg
recombin
viru
vaccin
satisfi
variou
criteria
met
vaccin
distribut
wild
kieni
et
al
wiktor
et
al
criteria
includ
vaccin
would
effect
deliv
oral
bait
bait
would
readili
accept
target
speci
would
rabi
virusfre
vaccin
bait
would
reason
longterm
genet
thermal
stabil
vaccin
would
biolog
contain
host
oral
exposur
bait
vaccin
would
produc
full
protect
rabi
viru
challeng
nontarget
speci
would
develop
rabi
ingest
bait
bait
clearli
identifi
safe
contact
human
extens
seri
trial
carri
usa
franc
criteria
met
vaccin
licens
raccoon
prevent
spread
raccoon
rabi
later
prevent
spread
mexican
dog
rabi
texa
coyot
along
south
texa
border
mexico
us
depart
agricultur
usda
wiktor
et
al
rupprecht
et
al
brochier
et
al
brochier
et
al
brochier
et
al
desmettr
et
al
singl
licens
product
produc
merial
inc
athen
ga
usa
rabor
vrg
tm
use
government
state
public
health
agenc
orv
raccoon
coyot
usa
rabor
vrg
tm
current
deliv
raccoon
coyot
extend
fishmeal
polym
bait
contain
mg
tetracyclin
hydrochlorid
bone
biomark
plastic
sachet
contain
ml
vaccin
extrud
poultrybas
bait
ident
vacdn
content
shown
effect
target
gray
fox
merial
inc
athen
ga
usa
success
use
orv
achiev
contain
elimin
rabi
terrestri
wildlif
anim
usa
canada
indic
effect
contain
near
elimin
red
fox
rabi
southern
ontario
macinn
et
al
canin
rabi
south
texa
fearneyhough
et
al
raccoon
rabi
ohio
kreb
et
al
southern
ontario
rosatt
et
al
eastern
new
brunswick
slate
et
al
million
bait
distribut
state
usa
slate
et
al
new
potenti
effect
oral
vector
vaccin
effect
bait
includ
fishmeal
coat
sachet
bait
develop
orv
slate
et
al
canarypoxrabi
glycoprotein
recombin
vaccin
develop
found
effect
poxvirusrabi
glycoprotein
recombin
taylor
et
al
taylor
et
al
live
canarypox
viru
express
rabi
viru
glycoprotein
licens
usa
parenter
monoval
vaccin
cat
combin
rabi
vaccin
cat
felin
panleukopenia
viru
felin
parvoviru
felin
caliciviru
vaccin
includ
product
combin
canarypoxrabi
vaccin
wholecel
bacterin
neorickettsia
risticii
includ
also
licens
use
prevent
potomac
fever
hors
rabi
viru
glycoprotein
vaccin
current
licens
usa
compendium
recombin
adenovirusvector
vaccin
express
rabi
viru
glycoprotein
adrabgp
shown
capabl
induc
antibodi
immun
respons
greyhound
dog
immun
either
subcutan
intramuscularli
dog
previous
vaccin
rabi
low
rabi
antibodi
titer
tim
et
al
vaccin
hold
promis
rabi
viru
vaccin
dog
inactiv
vaccin
requir
rabi
viru
produc
high
concentr
initi
done
grow
viru
strain
primarili
pittmanmoor
pm
nil
pasteur
viru
pv
bhk
strain
brain
tissu
rabbit
babi
hamster
kidney
bhk
cell
suckl
mous
brain
smb
guinea
pig
brain
cell
chick
embryo
cell
ceo
vero
cell
substrat
precausta
soulebot
reculard
neonat
mice
use
lack
immunogen
allergen
myelin
caus
encephalomyel
occasion
note
anim
vaccin
earlier
smb
nto
kill
vaccin
product
method
use
tco
rabi
vaccin
allow
less
allergen
immunolog
product
green
rupprecht
variou
method
still
valid
use
render
viru
nonpathogen
essenti
inactiv
kill
vaccin
includ
limit
beta
propiolacton
bpl
uv
light
acetylethylamin
well
amin
phenol
formaldehyd
longer
recommend
viru
inactiv
reculard
commonli
use
inactiv
agent
bpl
inactiv
adjuv
ad
order
increas
immun
respons
antigen
common
adjuv
aluminum
hydroxid
aluminum
phosphat
saponin
cattl
vaccin
rare
oil
adjuv
precausta
soulebot
much
inform
cell
line
inactiv
method
adjuv
proprietari
report
specif
one
vaccin
stabil
inactiv
cell
cultur
vaccin
allow
rabi
vaccin
combin
vaccin
bacterin
canin
distemp
canin
adenoviru
type
leptospira
parvoviru
canin
cat
combin
vaccin
includ
felin
panleukopeniaviru
felin
parvoviru
felin
caliciviru
combin
rabi
footandmouth
diseas
vaccin
avail
cattl
sheep
goat
potenc
safeti
inactiv
rabi
vaccin
proven
quit
good
nation
institut
health
nih
us
depart
health
human
servic
dhh
adopt
mous
inocul
test
measur
potenc
inactiv
vaccin
seligmann
necessit
poor
perform
initi
manufactur
tissu
cultur
origin
vaccin
bunn
although
number
test
measur
vaccin
potenc
use
throughout
world
nih
test
consid
gold
standard
measur
abil
inactiv
vaccin
protect
mous
viru
challeng
nih
test
reli
challeng
exposur
immun
mice
one
viru
strain
cv
strain
thought
deriv
origin
pasteur
isol
baer
test
inher
bia
toward
vaccin
viru
strain
origin
compar
vaccin
efficaci
across
varieti
strain
ie
sad
fluri
strain
vaccin
use
prepar
vaccin
barth
et
al
bia
occur
nonpasteur
stain
vaccin
test
protect
potenti
wild
viru
strain
baer
wunderli
et
al
addit
nih
use
two
dose
vaccin
administ
oneweek
interv
intraperiton
challeng
two
week
later
vaccin
rout
quit
differ
use
routin
administr
rabi
vaccin
second
dose
prevent
evalu
vaccin
primari
immunolog
potenti
challeng
result
disrupt
bloodbrain
barrier
allow
neutral
antibodi
serum
prevent
infect
result
limit
acknowledg
nih
test
need
improv
suggest
new
rabi
potenc
test
may
need
two
recent
report
propos
altern
method
avoid
shortcom
wunderli
et
al
wunderli
et
al
due
higher
antigen
mass
use
adjuv
inactiv
rabi
vaccin
produc
postvaccin
local
system
reaction
common
nonneurolog
reaction
includ
sore
lame
region
lymphadenopathi
inject
limb
fever
anaphylaxi
also
report
dreesen
green
rupprecht
focal
vascul
granuloma
seen
month
vacdnat
green
rupprecht
postvaccin
sarcoma
may
develop
result
sustain
inflammatori
reaction
site
vaccin
involv
underli
derma
postvaccin
sarcoma
often
aggress
invas
esped
cat
month
year
follow
vaccin
dubielzig
et
al
kass
et
al
green
rupprecht
review
case
fibrosarcoma
cat
follow
singl
vacdnat
show
cat
vaccinationsit
tumor
receiv
rabi
vaccin
administ
nonrabi
combin
vaccin
receiv
felin
leukemia
vaccin
hendrick
et
al
unusu
palpabl
lesion
occur
cat
administ
kill
vaccin
subcutan
schulz
et
al
advers
incid
rate
reaction
rabi
vaccin
retrospect
studi
ferret
rabi
vaccin
given
alon
given
combin
distemp
vaccin
common
advers
event
vomit
diarrhea
moor
et
al
new
gener
vector
recombin
vaccin
appear
market
avipoxviru
vaccin
recent
licens
use
cat
usa
rabi
glycoprotein
live
canarypox
vector
vaccin
appear
produc
allerg
neoplast
reaction
green
dreesen
green
rupprecht
world
survey
rabi
report
least
countri
territori
report
produc
anim
rabi
vaccin
product
anim
rabi
vaccin
countri
use
cell
cultur
seven
use
neural
tissu
six
countri
use
embryon
egg
four
countri
produc
one
type
vaccin
mlv
inactiv
vaccin
produc
worldwid
world
survey
rabi
report
brazil
major
produc
nto
rabi
vaccin
anim
use
follow
bangladesh
romania
tunisia
salvador
five
countri
account
million
dose
nto
vaccin
primarili
smb
origin
fuenzalida
strain
report
produc
year
survey
report
usa
produc
approxim
million
dose
tco
rabi
vaccin
tco
anim
vaccin
produc
vietnam
reportedli
primari
sourc
embryon
eggorigin
anim
vaccin
produc
vaccin
produc
worldwid
note
argentina
franc
germani
india
number
countri
presum
produc
anim
rabi
vaccin
contribut
report
period
avail
rabi
vaccin
dog
cat
latin
america
grew
total
dose
vaccin
administ
speci
rose
redipra
vaccin
coverag
increas
brazil
southern
cone
argentina
chile
paraguay
uruguay
howev
declin
andean
area
bolivia
columbia
ecuador
peru
venezuela
declin
central
america
report
denot
andean
area
canin
popul
vaccin
southern
cone
brazil
central
america
mexico
latin
caribbean
recommend
dog
popul
effect
immun
prevent
epidem
canin
rabi
coleman
dye
laboratori
confirm
canin
rabi
case
latin
america
period
cattl
account
case
domest
anim
account
case
respect
mani
type
rabi
vaccin
current
market
usa
use
domest
anim
inactiv
monoval
rabi
vaccin
licens
dog
cat
two
ferret
four
hors
four
cattl
five
sheep
two
inactiv
vaccin
combin
biolog
use
hors
new
gener
vaccin
licens
use
cat
live
canarypoxrabi
viru
glycoprotein
recombin
vector
vaccin
either
monoval
one
licens
vaccin
combin
felin
panleukopenia
viru
felin
parvoviru
felin
caliciviru
vaccin
compendium
live
vacciniarabi
viru
glycoprotein
recombin
vector
vaccin
licens
restrict
use
wildlif
raccoon
coyot
state
earlier
mlv
attenu
rabi
vaccin
licens
use
usa
current
licens
kill
rabi
vaccin
intend
use
carnivor
must
protect
statist
equival
number
anim
im
challeng
rabi
viru
day
post
challeng
control
must
die
challeng
code
feder
regul
altern
challeng
requir
outlin
test
anim
speci
carnivor
code
feder
regul
us
depart
agricultur
usda
anim
plant
health
inspect
servic
aphi
center
veterinari
biolog
jurisdict
licensur
rabi
vaccin
usa
nation
associ
state
public
health
veterinarian
nasphv
publish
annual
compendium
anim
rabi
prevent
control
compendium
compendium
basi
anim
rabi
program
nasphv
issu
recommend
state
eg
georgia
variou
citi
counti
adopt
recommend
compendium
regul
anim
rabi
control
prevent
inactiv
tco
vaccin
use
anim
month
age
older
one
year
later
minimum
age
preclud
matern
antibodi
blockag
recogn
immatur
immun
system
often
poor
respons
green
dreesen
depend
vaccin
anim
speci
time
local
regul
anim
vaccin
annual
triennial
thereaft
compendium
depend
vaccin
type
speci
vaccin
administ
either
im
sc
vaccin
administ
either
way
minimum
age
anim
vaccin
week
age
licens
vector
vaccin
regardless
rabi
vaccin
type
antibodi
respons
peak
approxim
day
primari
vaccin
anim
consid
fulli
immun
vaccin
administ
accord
manufactur
recommend
epidemiolog
viewpoint
effect
canin
rabi
prevent
control
program
measur
compar
report
rabi
dog
report
increas
cat
rabi
appar
recent
raccoon
rabi
epidem
middl
atlant
northeastern
usa
kreb
et
al
hanlon
rupprecht
increas
rabi
case
cat
dog
rabi
case
remain
substanti
unchang
reflect
vaccin
statu
two
popul
well
number
feral
anim
two
popul
eng
et
al
petronek
dreesen
respond
survey
state
commun
health
offici
johnson
walden
state
canin
rabi
vaccin
requir
state
law
state
cat
vaccin
state
law
need
cat
vaccin
feral
popul
control
overemphas
dreesen
johnson
walden
survey
also
note
overthecount
sale
rabi
vaccin
permit
state
time
vaccin
wolfhybrid
permit
state
howev
two
state
owner
must
sign
liabil
statement
fourteen
state
address
wolfhybrid
issu
extens
studi
center
diseas
control
prevent
niezgoda
et
al
rabi
vaccin
ferret
approv
usda
aphi
ferret
treat
similar
manner
dog
cat
regard
vaccin
postexposur
manag
compendium
vaccin
wolfhybrid
canin
rabi
vaccin
still
matter
consider
debat
meet
taxonomist
conclud
rabi
vaccin
dog
would
probabl
protect
wolv
hybrid
genet
virtual
indistinct
domest
dog
dreesen
least
one
welldocu
case
rabi
occur
properli
vaccin
wolfhybrid
jay
et
al
anim
vaccin
vaccin
month
age
receiv
vaccin
bacterin
antihelminth
day
six
month
later
anim
found
dead
skunk
mouth
within
week
anim
develop
sign
suggest
rabi
euthan
rabi
confirm
laboratori
current
licens
rabi
vaccin
wolfhybrid
compendium
state
wild
anim
hybrid
offspr
wild
anim
crossbr
domest
anim
kept
pet
anim
consid
immun
rabi
viru
exposur
approxim
day
primari
rabi
vaccin
consist
peak
antibodi
respons
compendium
thu
anim
consid
immun
primari
vaccin
administ
least
day
previous
followup
vaccin
administ
recommend
packag
insert
andor
compendium
nasphv
compendium
recommend
unvaccin
dog
cat
ferret
expos
known
suspect
rabid
anim
euthan
immedi
euthan
anim
place
strict
quarantin
month
vaccin
either
upon
entri
isol
one
month
prior
releas
anim
expir
vaccin
evalu
casebycas
basi
current
vaccin
dog
cat
ferret
revaccin
immedi
follow
exposur
kept
control
observ
day
shown
evid
use
vaccin
alon
reliabl
prevent
rabi
occur
unvaccin
domest
anim
hanlon
et
al
vacdnat
livestock
expos
rabi
revaccin
observ
day
compendium
previous
vaccin
food
anim
slaughter
within
day
dispos
tissu
expos
area
slaughter
within
time
period
anim
close
observ
month
previous
mention
compendium
issu
recommend
state
strictli
adher
recommend
exampl
texa
health
safeti
code
origin
follow
previous
note
recommend
anim
expos
rabi
clark
wilson
howev
code
amend
unvaccin
domest
anim
expos
rabid
anim
euthan
vaccin
immedi
exposur
kept
isol
day
given
booster
vaccin
third
eighth
week
isol
regimen
base
loos
recommend
human
expos
rabi
viru
retrospect
studi
conduct
clark
wilson
found
unvaccin
anim
develop
rabi
period
recommend
nasphv
follow
two
pep
failur
occur
period
texa
code
amend
allow
pep
unvaccin
anim
expos
rabi
anim
receiv
pep
booster
vaccin
die
rabi
statist
differ
two
regimen
condit
follow
texa
followup
studi
year
wilson
clark
found
four
domest
anim
receiv
pep
protocol
recommend
previou
period
develop
clinic
rabi
conclud
effect
pep
protocol
proven
effect
control
rabi
anim
altern
method
pep
unvaccin
domest
anim
expos
rabi
practic
texa
endors
compendium
